Ferritin Quantitative Test

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay)

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Ferritin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of malignant tumor or inflammation.

Product Detail

Application

Ferritin is a soluble tissue protein that stores iron in the human body. It is the most iron-rich protein complex, with a molecular weight of about 450,000 and containing 17% to 23% iron. Ferritin exists in various tissues and cells, especially in the liver, spleen, bone marrow, brain, and peripheral blood cells, including red blood cells, white blood cells, and platelets. Normal human serum contains a small amount of ferritin.

 

Ferritin plays an important dual role in the human body. It serves as a "reservoir" of iron for hemoglobin synthesis, and it also acts as a hollowed-in spherical protein that protects cells from excessive amounts of free iron, which can cause harmful effects.

 

Certain conditions can lead to increased ferritin levels in the body:

1. Acute infections and inflammatory diseases can promote the production of ferritin, the natural iron storage protein.

2. Hyperthyroidism can also cause ferritin to rise.

3. The increase of ferritin in malignant tumors is due to tumor invasion and necrosis, as well as the reduced ability of the liver to clear ferritin, and the increased synthesis of ferritin in tumor cells.

 

Specific types of cancer that can increase ferritin levels include:

Acute non-lymphocytic leukemia

Lymphoma

Liver cancer

Pancreatic cancer

Lung cancer

 

However, esophageal cancer, stomach cancer, colon cancer, and urinary system malignancies do not significantly affect ferritin levels.

 

Serum ferritin measurement can be used as a therapeutic indicator. Serum ferritin levels decrease in patients with effective treatment, but increase in patients with deterioration and recurrence. Continued increase in ferritin levels is associated with a poor prognosis. Therefore, serum ferritin measurement can be particularly useful for patients with alpha-fetoprotein-negative conditions.

 

Product Specification

Sample Volume

WB: 20μL; Serum/Plasma: 10μL

Test Time

10 mins

Measuring Range

0.50-1000 ng/mL

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Iron Deficiency Anemia Diagnosis

Monitoring Iron Status

Evaluation of Fatigue and Weakness

Assessment of Hemochromatosis

Guiding Iron Supplementation

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the 25-hydroxyvitamin D (25 (OH) D) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of health check.
biotime tPSA Rapid Quantitative Test
tPSA Rapid Quantitative Test
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood.
HSV-1 IgG/IgM Rapid Test (Fluorescence Immunoassay)
HSV-1 IgG/IgM Rapid Test (Fluorescence Immunoassay)
The HSV-1 IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies to HSV1 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. HSV-1 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses 1 (HSV-1) infection -For in vitro diagnostic use only. For professional use only.
Biotime 3 in 1 (cTnI/CK-MB/Myo) rapid fluorescence immunoassay test
3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test
3 in 1 test kit has a very high specificity and sensitivity for the detection of AMI, making a correct and timely diagnosis for patients with chest pain or clinically suspected AMI, and thus providing validly basis for clinicians with prompt rescue and treatment.
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Heparin binding protein (HBP) concentration in human plasma that contains Sodium Citrate samples, mainly used for auxiliary diagnosis of inflammation diseases.
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the total thyroxine 4 (TT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.
AMH Rapid Quantitative Test (Chemiluminescence Immunoassay)
AMH Rapid Quantitative Test (Chemiluminescence Immunoassay)
AMH Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Anti-Mullerian hormone (AMH) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.
Biotime ST2 Rapid Quantitative Test
ST2 Rapid Quantitative Test
ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact